Sunrest Lifescience Ltd
Incorporated in 2017, Sunrest Lifescience Ltd trades in Health care and Cosmetics products[1]
- Market Cap ₹ 18.0 Cr.
- Current Price ₹ 42.0
- High / Low ₹ 75.0 / 40.2
- Stock P/E 8.97
- Book Value ₹
- Dividend Yield 0.00 %
- ROCE %
- ROE %
- Face Value ₹ 10.0
Pros
Cons
- Promoter holding has decreased over last quarter: -16.4%
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Peer comparison
Healthcare Healthcare Pharmaceuticals & Biotechnology Pharmaceuticals
Quarterly Results
Consolidated Figures in Rs. Crores / View Standalone
| Operating Profit |
| OPM % |
| Interest |
| Depreciation |
| Profit before tax |
| Tax % |
| EPS in Rs |
| Raw PDF |
Profit & Loss
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2025 | |
|---|---|
| 33.41 | |
| 30.38 | |
| Operating Profit | 3.03 |
| OPM % | 9.07% |
| 0.00 | |
| Interest | 0.31 |
| Depreciation | 0.10 |
| Profit before tax | 2.62 |
| Tax % | 23.28% |
| 2.01 | |
| EPS in Rs | 4.68 |
| Dividend Payout % | 0.00% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| TTM: | % |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| TTM: | % |
| Stock Price CAGR | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| 1 Year: | -28% |
| Return on Equity | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| Last Year: | % |
Balance Sheet
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2025 | |
|---|---|
| Equity Capital | |
| Reserves | |
| Total Liabilities | |
| CWIP | |
| Investments | |
| Total Assets |
Cash Flows
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2025 | |
|---|---|
| 1.43 | |
| -1.15 | |
| -0.33 | |
| Net Cash Flow | -0.04 |
Ratios
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2025 | |
|---|---|
| Debtor Days | |
| Inventory Days | |
| Days Payable | |
| Cash Conversion Cycle | |
| Working Capital Days | |
| ROCE % |
Documents
Announcements
-
Quarterly Compliance Report on Corporate governance - within 21 days from the end of the quarter
18 October 2025 - SME-listed Sunrest Lifescience exempt from SEBI governance rules for quarter ended 30 Sep 2025; paid-up Rs4.29cr, net worth Rs16.18cr.
-
Certificate under SEBI (Depositories and Participants) Regulations, 2018
8 October 2025 - Certificate under Regulation 74(5) for quarter ended 30 September 2025 submitted by registrar Skyline Financial.
-
Structural Digital Database
8 October 2025 - SDD Compliance Certificate for quarter ended 30 September 2025; no non-compliances reported.
-
Appointment
27 September 2025 - Shareholders approved appointment of M/s Jinang Shah & Associates as secretarial auditor for FY2025-26 to FY2029-30 on 27-Sep-2025.
-
Shareholders meeting
27 September 2025 - 8th AGM held 27-Sep-2025; adopted FY2024-25 financials; reappointed two directors; approved material related-party transactions.
Business Overview:[1][2]
SLSL is in the business of trading of Pharmaceutical Product on wholesale and retail basis. It provides OTC brands in healthcare & personal care viz. Capsules, Tablets, Syrup, Ointment, Gel, mouthwash, Solution, Suspension, Dry Powders, and Toothpaste